Gilead disputes report of anti-viral drug remdesivir failing Covid-19 trial

It comes days after another report of rapid recovery in fever and respiratory symptoms in some patients with Covid-19 who were treated with remdesivir at the University of Chicago Medicine hospital

from Companies https://ift.tt/3aBYAE6
via IFTTT